DualityBioBeyond's analysis on DualityBio2026-08-28 — DualityBio’s DUPAC payload platform gains validation through a global ADC collaboration with Genentech, potentially accelerating next‑generation cancer therapeuticsRecent news mentioning DualityBio2026-08-28 — DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload PlatformBrowse the full archive →